Maravai Lifesciences Holdings Inc Cl A (MRVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 322,399 | 574,962 | 632,138 | 551,272 | 236,184 |
| Receivables | 38,520 | 54,605 | 146,814 | 117,512 | 51,018 |
| Inventories | 50,082 | 51,397 | 43,152 | 51,557 | 33,301 |
| TOTAL | $429,146 | $699,912 | $847,902 | $740,039 | $331,598 |
| Non-Current Assets | |||||
| PPE Net | 164,474 | 162,900 | 52,694 | 46,332 | 101,305 |
| Intangibles | 354,835 | 547,016 | 500,331 | 270,337 | 401,931 |
| Other Non-Current Assets | 59,789 | 77,622 | 881,388 | 861,568 | 435,857 |
| TOTAL | $579,098 | $787,538 | $1,434,413 | $1,178,237 | $939,093 |
| Total Assets | $1,008,244 | $1,487,450 | $2,282,315 | $1,918,276 | $1,270,691 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,440 | 5,440 | 5,440 | 6,000 | 6,000 |
| Accounts payable and accrued liabilities | 11,957 | 10,729 | 5,991 | 8,154 | 8,171 |
| Accrued Expenses | 36,407 | 60,237 | 53,371 | 34,574 | 38,546 |
| TOTAL | $56,971 | $87,468 | $110,144 | $93,777 | $130,778 |
| Non-Current Liabilities | |||||
| Long Term Debt | 290,492 | 518,707 | 521,997 | 524,591 | 528,614 |
| Deferred Revenues | 2,375 | 3,360 | 3,088 | 10,211 | 78,061 |
| Other Non-Current Liabilities | 167,242 | 78,840 | 474,473 | 467,334 | 405,119 |
| TOTAL | $374,064 | $610,098 | $1,266,928 | $1,279,138 | $985,167 |
| Total Liabilities | $431,035 | $697,566 | $1,377,072 | $1,372,915 | $1,115,945 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 254,336 | 251,400 | 250,879 | 255,159 | N/A |
| Common Shares | 2,527 | 2,513 | 2,554 | 2,552 | 2,576 |
| Retained earnings | 140,891 | 285,737 | 404,766 | 184,561 | 854 |
| Other shareholders' equity | 251,917 | 373,131 | 360,025 | 229,862 | 66,191 |
| TOTAL | $577,209 | $789,884 | $905,243 | $545,361 | $154,746 |
| Total Liabilities And Equity | $1,008,244 | $1,487,450 | $2,282,315 | $1,918,276 | $1,270,691 |